US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 1.7850
  • -0.0950-5.05%
Trading Mar 25 11:13 ET
65.45MMarket Cap-0.45P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-73.83%217.76K
13.97%116.99K
0
-55.41%100.76K
0
-91.89%832.01K
-17.66%102.65K
-95.76%388.45K
-71.19%225.97K
-42.26%114.94K
Operating revenue
-73.83%217.76K
13.97%116.99K
--0
-55.41%100.76K
--0
-91.89%832.01K
-17.66%102.65K
-95.76%388.45K
-71.19%225.97K
-42.26%114.94K
Cost of revenue
Gross profit
Operating expense
-16.12%112.62M
-25.49%20.49M
7.55%27.35M
-10.65%33.3M
-28.55%31.48M
-51.68%134.26M
-50.96%27.5M
-43.38%25.43M
-64.48%37.27M
-38.74%44.07M
Selling and administrative expenses
-22.25%37M
-25.79%7.6M
-13.21%8.61M
-24.52%10.21M
-23.90%10.57M
-47.24%47.58M
-26.58%10.24M
-16.06%9.93M
-72.09%13.52M
-12.93%13.89M
-General and administrative expense
-22.25%37M
-25.79%7.6M
-13.21%8.61M
-24.52%10.21M
-23.90%10.57M
-47.24%47.58M
-26.58%10.24M
-16.06%9.93M
-72.09%13.52M
-12.93%13.89M
Research and development costs
-12.76%75.62M
-25.31%12.89M
20.84%18.73M
-2.75%23.09M
-30.70%20.91M
-53.81%86.68M
-59.04%17.25M
-53.14%15.5M
-57.95%23.74M
-46.09%30.18M
Operating profit
15.76%-112.4M
25.64%-20.37M
-9.22%-27.35M
10.38%-33.2M
28.37%-31.48M
50.13%-133.43M
51.04%-27.39M
29.97%-25.04M
64.43%-37.04M
38.73%-43.95M
Net non-operating interest income expense
-33.59%4.59M
-44.52%852.59K
-31.90%1.11M
-29.51%1.31M
-30.16%1.32M
95.87%6.91M
-2.44%1.54M
54.45%1.63M
240.83%1.85M
431.45%1.89M
Non-operating interest income
-41.39%4.77M
-53.13%852.59K
-42.91%1.11M
-39.70%1.31M
-32.03%1.5M
70.08%8.13M
-3.69%1.82M
41.95%1.94M
152.81%2.17M
229.52%2.21M
Non-operating interest expense
-85.46%177.83K
--0
--0
--0
-43.27%177.83K
-2.49%1.22M
-9.94%282.33K
0.00%313.49K
0.00%313.49K
0.00%313.49K
Other net income (expense)
106.46%555.64K
-84.14%135.3K
110.23%1.08M
0.18%-347.54K
-121.81%-307.36K
36.79%-8.6M
1,024.61%853.29K
-241.51%-10.52M
92.90%-348.18K
125.47%1.41M
Gain on sale of security
-16.49%4.89M
59.42%3.07M
706.74%1.33M
-102.26%-20.82K
-84.44%500.88K
174.57%5.85M
-30.99%1.93M
88.04%-219.34K
123.26%922.94K
166.48%3.22M
Earnings from equity interest
-250.87%-1.17M
-380.11%-1.03M
51.25%324.25K
-313.27%-334.29K
-120.44%-126.02K
140.70%773.15K
-74.70%-214.61K
170.27%214.37K
116.78%156.75K
214.67%616.64K
Special income (charges)
--0
--0
--0
----
----
---10.51M
--0
---10.51M
----
----
-Less:Impairment of capital assets
--0
--0
--0
----
----
--10.51M
--0
--10.51M
----
----
Other non- operating income (expenses)
32.85%-3.16M
-121.77%-1.91M
-20,416.01%-579.82K
100.53%7.57K
71.88%-682.22K
-22.01%-4.71M
68.86%-860.91K
100.30%2.85K
-46,746.03%-1.43M
-1,480.57%-2.43M
Income before tax
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.34%-135.12M
54.09%-25M
10.20%-33.93M
67.25%-35.53M
47.15%-40.65M
Income tax
Net income
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
Net income continuous Operations
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
Minority interest income
Net income attributable to the parent company
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.62%-107.25M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
51.71%-135.12M
54.09%-25M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
Basic earnings per share
35.14%-3.95
44.44%-0.6
41.45%-0.89
26.09%-1.19
30.69%-1.31
56.72%-6.09
57.65%-1.08
15.56%-1.52
70.83%-1.61
56.25%-1.89
Diluted earnings per share
35.14%-3.95
44.44%-0.6
41.45%-0.89
26.09%-1.19
30.69%-1.31
56.72%-6.09
57.65%-1.08
15.56%-1.52
70.83%-1.61
56.25%-1.89
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -73.83%217.76K13.97%116.99K0-55.41%100.76K0-91.89%832.01K-17.66%102.65K-95.76%388.45K-71.19%225.97K-42.26%114.94K
Operating revenue -73.83%217.76K13.97%116.99K--0-55.41%100.76K--0-91.89%832.01K-17.66%102.65K-95.76%388.45K-71.19%225.97K-42.26%114.94K
Cost of revenue
Gross profit
Operating expense -16.12%112.62M-25.49%20.49M7.55%27.35M-10.65%33.3M-28.55%31.48M-51.68%134.26M-50.96%27.5M-43.38%25.43M-64.48%37.27M-38.74%44.07M
Selling and administrative expenses -22.25%37M-25.79%7.6M-13.21%8.61M-24.52%10.21M-23.90%10.57M-47.24%47.58M-26.58%10.24M-16.06%9.93M-72.09%13.52M-12.93%13.89M
-General and administrative expense -22.25%37M-25.79%7.6M-13.21%8.61M-24.52%10.21M-23.90%10.57M-47.24%47.58M-26.58%10.24M-16.06%9.93M-72.09%13.52M-12.93%13.89M
Research and development costs -12.76%75.62M-25.31%12.89M20.84%18.73M-2.75%23.09M-30.70%20.91M-53.81%86.68M-59.04%17.25M-53.14%15.5M-57.95%23.74M-46.09%30.18M
Operating profit 15.76%-112.4M25.64%-20.37M-9.22%-27.35M10.38%-33.2M28.37%-31.48M50.13%-133.43M51.04%-27.39M29.97%-25.04M64.43%-37.04M38.73%-43.95M
Net non-operating interest income expense -33.59%4.59M-44.52%852.59K-31.90%1.11M-29.51%1.31M-30.16%1.32M95.87%6.91M-2.44%1.54M54.45%1.63M240.83%1.85M431.45%1.89M
Non-operating interest income -41.39%4.77M-53.13%852.59K-42.91%1.11M-39.70%1.31M-32.03%1.5M70.08%8.13M-3.69%1.82M41.95%1.94M152.81%2.17M229.52%2.21M
Non-operating interest expense -85.46%177.83K--0--0--0-43.27%177.83K-2.49%1.22M-9.94%282.33K0.00%313.49K0.00%313.49K0.00%313.49K
Other net income (expense) 106.46%555.64K-84.14%135.3K110.23%1.08M0.18%-347.54K-121.81%-307.36K36.79%-8.6M1,024.61%853.29K-241.51%-10.52M92.90%-348.18K125.47%1.41M
Gain on sale of security -16.49%4.89M59.42%3.07M706.74%1.33M-102.26%-20.82K-84.44%500.88K174.57%5.85M-30.99%1.93M88.04%-219.34K123.26%922.94K166.48%3.22M
Earnings from equity interest -250.87%-1.17M-380.11%-1.03M51.25%324.25K-313.27%-334.29K-120.44%-126.02K140.70%773.15K-74.70%-214.61K170.27%214.37K116.78%156.75K214.67%616.64K
Special income (charges) --0--0--0-----------10.51M--0---10.51M--------
-Less:Impairment of capital assets --0--0--0----------10.51M--0--10.51M--------
Other non- operating income (expenses) 32.85%-3.16M-121.77%-1.91M-20,416.01%-579.82K100.53%7.57K71.88%-682.22K-22.01%-4.71M68.86%-860.91K100.30%2.85K-46,746.03%-1.43M-1,480.57%-2.43M
Income before tax 20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.34%-135.12M54.09%-25M10.20%-33.93M67.25%-35.53M47.15%-40.65M
Income tax
Net income 20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M10.20%-33.93M67.25%-35.53M48.59%-40.65M
Net income continuous Operations 20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M10.20%-33.93M67.25%-35.53M48.59%-40.65M
Minority interest income
Net income attributable to the parent company 20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M10.20%-33.93M67.25%-35.53M48.59%-40.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.62%-107.25M22.48%-19.38M25.83%-25.17M9.28%-32.24M25.04%-30.47M51.71%-135.12M54.09%-25M10.20%-33.93M67.25%-35.53M48.59%-40.65M
Basic earnings per share 35.14%-3.9544.44%-0.641.45%-0.8926.09%-1.1930.69%-1.3156.72%-6.0957.65%-1.0815.56%-1.5270.83%-1.6156.25%-1.89
Diluted earnings per share 35.14%-3.9544.44%-0.641.45%-0.8926.09%-1.1930.69%-1.3156.72%-6.0957.65%-1.0815.56%-1.5270.83%-1.6156.25%-1.89
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Enerpac Tool
EPAC
46.390
Precision Drilling
PDS
46.980
Workday
WDAY
252.150
4
Halozyme Therapeutics
HALO
64.540
5
eBay
EBAY
67.045
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025